$AAGH
America Great Health

2024 Q1 Form 10-Q Financial Statement

#000118518524000606 Filed on June 03, 2024

View on sec.gov

Income Statement

Concept 2024 Q1
Revenue $94.03K
YoY Change 138.35%
Cost Of Revenue $11.92K
YoY Change 6174.21%
Gross Profit $82.11K
YoY Change 109.14%
Gross Profit Margin 87.32%
Selling, General & Admin $216.4K
YoY Change 43.3%
% of Gross Profit 263.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.700K
YoY Change 0.0%
% of Gross Profit 4.51%
Operating Expenses $216.4K
YoY Change 43.3%
Operating Profit -$134.3K
YoY Change 20.16%
Interest Expense $94.27K
YoY Change -7.51%
% of Operating Profit
Other Income/Expense, Net -$94.25K
YoY Change -7.52%
Pretax Income -$228.5K
YoY Change 6.96%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$226.6K
YoY Change 6.04%
Net Earnings / Revenue -240.93%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 21.19B shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $51.74K
YoY Change -6.89%
Cash & Equivalents $51.74K
Short-Term Investments
Other Short-Term Assets $11.60K
YoY Change -31.64%
Inventory $133.1K
Prepaid Expenses
Receivables $69.80K
Other Receivables $0.00
Total Short-Term Assets $266.3K
YoY Change 42.0%
LONG-TERM ASSETS
Property, Plant & Equipment $46.60K
YoY Change -24.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.01K
YoY Change 21.81%
Total Long-Term Assets $67.12K
YoY Change -44.65%
TOTAL ASSETS
Total Short-Term Assets $266.3K
Total Long-Term Assets $67.12K
Total Assets $333.4K
YoY Change 7.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.448M
YoY Change 1.54%
Accrued Expenses $3.510K
YoY Change -91.19%
Deferred Revenue
YoY Change
Short-Term Debt $714.4K
YoY Change 193.65%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.254M
YoY Change 25.85%
LONG-TERM LIABILITIES
Long-Term Debt $1.123M
YoY Change -26.74%
Other Long-Term Liabilities $829.7K
YoY Change 51.75%
Total Long-Term Liabilities $1.123M
YoY Change -26.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.254M
Total Long-Term Liabilities $1.123M
Total Liabilities $5.207M
YoY Change 11.61%
SHAREHOLDERS EQUITY
Retained Earnings -$9.814M
YoY Change 9.76%
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.795M
YoY Change
Total Liabilities & Shareholders Equity $333.4K
YoY Change 7.97%

Cashflow Statement

Concept 2024 Q1
OPERATING ACTIVITIES
Net Income -$226.6K
YoY Change 6.04%
Depreciation, Depletion And Amortization $3.700K
YoY Change 0.0%
Cash From Operating Activities $103.9K
YoY Change -126.23%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -124.8K
YoY Change -131.16%
NET CHANGE
Cash From Operating Activities 103.9K
Cash From Investing Activities 0.000
Cash From Financing Activities -124.8K
Net Change In Cash -20.88K
YoY Change -584.45%
FREE CASH FLOW
Cash From Operating Activities $103.9K
Capital Expenditures $0.00
Free Cash Flow $103.9K
YoY Change -126.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-27873
dei Entity Registrant Name
EntityRegistrantName
America Great Health
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0178621
dei Entity Address Address Line1
EntityAddressAddressLine1
1609 W Valley Blvd Unit 338A
dei Entity Address City Or Town
EntityAddressCityOrTown
Alhambra
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91803
dei City Area Code
CityAreaCode
(888)
dei Local Phone Number
LocalPhoneNumber
988-1333
dei Security12b Title
Security12bTitle
N/A
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21188988326 shares
CY2024Q1 us-gaap Cash
Cash
51739 usd
CY2023Q2 us-gaap Cash
Cash
54150 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
69800 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
133139 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
108351 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11595 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16964 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
266273 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
179465 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3506 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
41918 usd
CY2024Q1 us-gaap Other Receivables
OtherReceivables
7000 usd
CY2023Q2 us-gaap Other Receivables
OtherReceivables
8218 usd
CY2024Q1 us-gaap Deposit Assets
DepositAssets
10011 usd
CY2023Q2 us-gaap Deposit Assets
DepositAssets
11836 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46600 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57692 usd
CY2024Q1 us-gaap Assets
Assets
333390 usd
CY2023Q2 us-gaap Assets
Assets
299129 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1447793 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1450574 usd
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4268 usd
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3970 usd
CY2024Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
714359 usd
CY2023Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
705216 usd
CY2024Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
237913 usd
CY2023Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
241784 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
631928 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
425142 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
214600 usd
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
223331 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3506 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
41918 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3254367 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3091935 usd
CY2024Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
829669 usd
CY2023Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
609892 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1123138 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1123138 usd
CY2024Q1 us-gaap Liabilities
Liabilities
5207174 usd
CY2023Q2 us-gaap Liabilities
Liabilities
4824965 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21188988326 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21188988326 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21090218148 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21090218148 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5019059 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4732477 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-197 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-500 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9814337 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9183110 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-4795475 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4451133 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
-78309 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
-74703 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4873784 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4525836 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
333390 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
299129 usd
CY2024Q1 us-gaap Revenues
Revenues
94032 usd
CY2023Q1 us-gaap Revenues
Revenues
39452 usd
us-gaap Revenues
Revenues
199019 usd
us-gaap Revenues
Revenues
129620 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11921 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
190 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20623 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
35688 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
82111 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
39262 usd
us-gaap Gross Profit
GrossProfit
178396 usd
us-gaap Gross Profit
GrossProfit
93932 usd
CY2024Q1 aagh Selling Expense1
SellingExpense1
3998 usd
CY2023Q1 aagh Selling Expense1
SellingExpense1
471 usd
aagh Selling Expense1
SellingExpense1
672 usd
aagh Selling Expense1
SellingExpense1
5877 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
212375 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
150525 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
540791 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
423117 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
216373 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
150996 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
541463 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
428994 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-134262 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-111734 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-363067 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-335062 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
94267 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
101919 usd
us-gaap Interest Expense
InterestExpense
271802 usd
us-gaap Interest Expense
InterestExpense
234459 usd
CY2024Q1 us-gaap Other Income
OtherIncome
22 usd
CY2023Q1 us-gaap Other Income
OtherIncome
6 usd
us-gaap Other Income
OtherIncome
36 usd
us-gaap Other Income
OtherIncome
34999 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-94245 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-101913 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-271766 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-199460 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-228507 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-213647 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-634833 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-534522 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-228507 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-213647 usd
us-gaap Profit Loss
ProfitLoss
-634833 usd
us-gaap Profit Loss
ProfitLoss
-534522 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1957 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-918 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3606 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-14888 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-226550 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-212729 usd
us-gaap Net Income Loss
NetIncomeLoss
-631227 usd
us-gaap Net Income Loss
NetIncomeLoss
-519634 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
366 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
59 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-197 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
464 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-226184 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-212670 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-631424 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-519170 usd
CY2024Q1 aagh Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
0
CY2023Q1 aagh Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
0
aagh Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
0
aagh Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
0
CY2024Q1 aagh Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
21173184947 shares
CY2023Q1 aagh Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
21090938148 shares
aagh Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
21173184947 shares
aagh Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
21090938148 shares
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-3860481 usd
aagh Imputed Interest
ImputedInterest
5206 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
32400 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
465 usd
us-gaap Profit Loss
ProfitLoss
-534522 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4356932 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4525836 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
28000 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
44601 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
115000 usd
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
98981 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
302 usd
us-gaap Profit Loss
ProfitLoss
-634833 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4873784 usd
us-gaap Profit Loss
ProfitLoss
-634833 usd
us-gaap Profit Loss
ProfitLoss
-534522 usd
us-gaap Depreciation
Depreciation
11092 usd
us-gaap Depreciation
Depreciation
6649 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
126981 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
17200 usd
us-gaap Share Based Compensation
ShareBasedCompensation
44601 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
aagh Imputed Interest
ImputedInterest
0 usd
aagh Imputed Interest
ImputedInterest
5206 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
69800 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
308 usd
aagh Increase Decrease In Supplier Advances
IncreaseDecreaseInSupplierAdvances
5369 usd
aagh Increase Decrease In Supplier Advances
IncreaseDecreaseInSupplierAdvances
0 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1825 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
24788 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2300 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2781 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-15197 usd
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
-8731 usd
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
26019 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
62201 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
23337 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
170050 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
170528 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1219 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4363 usd
us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
-3572 usd
us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
-118396 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1624 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-321167 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-417923 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
44420 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44420 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
25000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
125000 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
23966 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
65660 usd
us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
4366 usd
us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
23337 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
601000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
100000 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
383089 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
194020 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
176303 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
291420 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
115000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15200 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
318454 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
454803 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
302 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
465 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2411 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7075 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54150 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62643 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51739 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55568 usd
us-gaap Interest Paid
InterestPaid
4366 usd
us-gaap Interest Paid
InterestPaid
23337 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
800 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
800 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
28000 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
0 usd
CY2017Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
16155746000 shares
CY2017Q1 us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
100 usd
CY2020Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
510000000 shares
CY2021Q3 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
50000 usd
CY2021Q3 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
53 pure
CY2021Q3 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
19 pure
CY2021Q3 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
7626286.37 usd
CY2021Q3 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
7000000 usd
CY2021Q3 aagh Real Estate Description Of Terms
RealEstateDescriptionOfTerms
$1,000,000 on execution of the Agreement, (ii) $2,000,000 within 60 days thereof and (iii) the remainder by April 10, 2022. The Agreement is subject to customary closing conditions, including, satisfactory due diligence. On September 9, 2021, the Company entered into a Supplemental Assets Acquisition Agreement with Wang’s Property Investment & Management LLC to amend and clarify that (i) it was purchasing 19 real estate properties which includes 53 units appraised at $7,626,286.37 for a purchase price of $7,000,000 and (ii) that it will waive and not conduct due diligence in order for the transaction to proceed. The acquisition has not been consummated.
CY2021Q4 aagh Class Of Warrant Or Rights Granted
ClassOfWarrantOrRightsGranted
500000 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
CY2021Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P24M
CY2022Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
500000 shares
CY2021Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
20000000 shares
CY2022Q4 aagh Agreement Description
AgreementDescription
The Company A agrees that if the patent is sold or transferred, Men Hwei, Tsai or Men Hwei, Tsai's successor may receive a 25% gain on the transfer or sale of the interest. The Company agrees to give Men Hwei, Tsai an additional 20 million AAGH shares. The Company allows Men Hwei, Tsai to use three years (from November 26, 2022 to November 25, 2025) find investors each with more than US$10 million investment. In case that no investor is found within three years, Men Hwei, Tsai agrees to return the patent to the Company, and both parties will continue to cooperate in accordance with the original contract on May 18, 2021. If Men Hwei, Tsai finds an investor with an investment of at least US$10 million within three years, and the process for Men Hwei, Tsai and its investors to apply for a new drug may last for several years, then Men Hwei, Tsai agrees that the Company will use the patented technology to develop dietary supplement that are helpful to Alzheimer’s disease. The Company will be responsible for marketing the dietary supplement. Men Hwei, Tsai is entitled to commission equaling to 8% of sales price.
CY2022Q4 us-gaap Other Commitment
OtherCommitment
34978.48 usd
us-gaap Profit Loss
ProfitLoss
-634833 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-321167 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4873784 usd
CY2024Q1 us-gaap Cash
Cash
51739 usd
CY2024Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
69800 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
133139 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
108351 usd
CY2027Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.12 pure
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Estimates</b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates include accounting for potential liabilities and the assumptions made in valuing stock instruments issued for services, debt and equity investment. Actual results could differ from those estimates.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q1 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1 pure
CY2024Q1 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1 pure
CY2024Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
1268 usd
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
4131 usd
CY2024Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.20 pure
CY2025Q2 us-gaap Long Term Debt
LongTermDebt
1123138 usd
CY2025 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
0 usd
CY2025 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
224628 usd
CY2024Q1 us-gaap Deposit Assets
DepositAssets
10011 usd
CY2023Q2 us-gaap Deposit Assets
DepositAssets
11836 usd
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
82116 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
62348 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
51023 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
46003 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
133139 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
108351 usd
CY2025Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.20 pure
CY2026Q2 us-gaap Long Term Debt
LongTermDebt
803138 usd
CY2026 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
640000 usd
CY2026 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
112616 usd
CY2026Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.14 pure
CY2027Q2 us-gaap Long Term Debt
LongTermDebt
572069 usd
CY2027 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
462138 usd
CY2027 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
68935 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
73943 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
74943 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
27343 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16251 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46600 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57692 usd
us-gaap Depreciation
Depreciation
11092 usd
us-gaap Depreciation
Depreciation
6649 usd
CY2024Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
714359 usd
CY2023Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
705216 usd
CY2024Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
714359 usd
CY2023Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
705216 usd
CY2023 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1123138 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1123138 usd
CY2024Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.20 pure
CY2022Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.16 pure
CY2024Q1 us-gaap Long Term Debt Term
LongTermDebtTerm
P5Y
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1123138 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
571701 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
1694839 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
1123138 usd
CY2024 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
0 usd
CY2024 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
224628 usd
CY2028Q2 us-gaap Long Term Debt
LongTermDebt
561569 usd
CY2028 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
21000 usd
CY2028 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
3057 usd
CY2028Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.01 pure
CY2029Q2 us-gaap Long Term Debt
LongTermDebt
0 usd
CY2029 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
0 usd
CY2029 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
0 usd
CY2029Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0 pure
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21188988326 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21188988326 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21090218148 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21090218148 shares
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1300000 shares
CY2022Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.075
CY2024Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1500000 shares
CY2024Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.01
CY2023Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
6488867 shares
CY2023Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.004
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25955 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
4881311 shares
CY2024Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.02
CY2024Q1 us-gaap Security Owned Not Readily Marketable Fair Value
SecurityOwnedNotReadilyMarketableFairValue
18645 usd
CY2024Q1 us-gaap Restricted Stock Shares Issued Net Of Shares For Tax Withholdings
RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
1000000 shares
CY2024Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
80000 usd
CY2024Q1 us-gaap Share Price
SharePrice
0.02
CY2023Q4 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
7000000 shares
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
40000 usd
CY2023Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.20 pure
CY2023Q4 us-gaap Debt Instrument Term
DebtInstrumentTerm
P3Y
CY2023Q4 us-gaap Debt Instrument Description
DebtInstrumentDescription
The shares issued are restricted and will be returned to the Company after the principal and interest are paid in full. During the investment period, if the stock can be normally traded in the stock market, and the market value of this part of AAGH stock exceeds the principal and interest of loan for 30 consecutive trading days. The remaining principal and interest of loans will be forgiven.
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21173184947 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21173184947 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21092868697 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21092868697 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18127152400 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17009942312 shares
us-gaap Operating Lease Expense
OperatingLeaseExpense
63855 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
50793 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y2M1D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05 pure
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3528 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3528 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
0 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
0 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
0 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3528 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
22 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3506 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3506 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001098009
dei No Trading Symbol Flag
NoTradingSymbolFlag
true

Files In Submission

Name View Source Status
0001185185-24-000606-index-headers.html Edgar Link pending
0001185185-24-000606-index.html Edgar Link pending
0001185185-24-000606.txt Edgar Link pending
0001185185-24-000606-xbrl.zip Edgar Link pending
aagh-20240331.xsd Edgar Link pending
amgreat20240331_10q.htm Edgar Link pending
ex_682291.htm Edgar Link pending
ex_682292.htm Edgar Link pending
aagh-20240331_cal.xml Edgar Link unprocessable
aagh-20240331_def.xml Edgar Link unprocessable
amgreat20240331_10q_htm.xml Edgar Link completed
ex_682293.htm Edgar Link pending
ex_682294.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
aagh-20240331_lab.xml Edgar Link unprocessable
aagh-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable